{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:04Z","timestamp":1779926404985,"version":"3.53.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":135,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.14283\/jpad.2024.40","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T10:14:12Z","timestamp":1707387252000},"page":"672-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Anti-Hypertensive Drugs Moderate the Relationship of Blood Pressure with Alzheimer's Pathologies and Neurodegenerative Markers in Non-Demented Hypertensive Older Adults"],"prefix":"10.1016","volume":"11","author":[{"given":"Y.","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-C.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.14283\/jpad.2024.40_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s12888-016-1132-y","article-title":"Technology-enhanced multi-domain at home continuum of care program with respect to usual care for people with cognitive impairment: the Ability-TelerehABILITation study protocol for a randomized controlled trial","volume":"16","author":"Realdon","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.14283\/jpad.2024.40_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/B978-0-12-804766-8.00013-3","article-title":"Alzheimer's disease","volume":"167","author":"Soria Lopez","year":"2019","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"10.14283\/jpad.2024.40_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1053-8119(02)00026-5","article-title":"Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging","volume":"18","author":"Chetelat","year":"2003","journal-title":"Neuroimage"},{"issue":"1","key":"10.14283\/jpad.2024.40_bib4","first-page":"25","article-title":"Medial temporal lobe volumetrics in traumatic brain injury","volume":"18","author":"Jack","year":"1997","journal-title":"AJNR Am J Neuroradiol"},{"issue":"10248","key":"10.14283\/jpad.2024.40_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.14283\/jpad.2024.40_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/alz.12377","article-title":"Tau pathologies mediate the association of blood pressure with cognitive impairment in adults without dementia: The CABLE study","volume":"18","author":"Hu","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.14283\/jpad.2024.40_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/HYPERTENSIONAHA.120.14993","article-title":"Blood Pressure and Risks of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of 209 Prospective Studies","volume":"76","author":"Ou","year":"2020","journal-title":"Hypertension"},{"issue":"24","key":"10.14283\/jpad.2024.40_bib8","doi-asserted-by":"crossref","first-page":"e2446","DOI":"10.1212\/WNL.0000000000200302","article-title":"Visit-to-Visit Blood Pressure Variability and CSF Alzheimer Disease Biomarkers in Cognitively Unimpaired and Mildly Impaired Older Adults","volume":"98","author":"Sible","year":"2022","journal-title":"Neurology"},{"issue":"1","key":"10.14283\/jpad.2024.40_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1474-4422(19)30393-X","article-title":"Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies","volume":"19","author":"Ding","year":"2020","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.14283\/jpad.2024.40_bib10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","article-title":"Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial","volume":"7","author":"Peters","year":"2008","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.14283\/jpad.2024.40_bib11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1474-4422(08)70144-3","article-title":"Antihypertensive treatment and dementia prevention","volume":"7","author":"Skoog","year":"2008","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.14283\/jpad.2024.40_bib12","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1212\/WNL.0000000000008732","article-title":"Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis","volume":"94","author":"Peters","year":"2020","journal-title":"Neurology"},{"key":"10.14283\/jpad.2024.40_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neurobiolaging.2021.04.009","article-title":"Vi sit-to-vi sit blood pressure variability and regional cerebral perfusion decline in older adults","volume":"105","author":"Sible","year":"2021","journal-title":"Neurobiology of aging"},{"issue":"12","key":"10.14283\/jpad.2024.40_bib14","volume":"10","year":"2018","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.14283\/jpad.2024.40_bib15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3233\/JAD-2010-091150","article-title":"The amnestic syndrome of hippocampal type in Alzheimer's disease: an MRI study","volume":"22","author":"Sarazin","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.14283\/jpad.2024.40_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.0b013e318204a397","article-title":"Genome-wide association study of CSF biomarkers Abetal-42, t-tau, and p-taul81p in the ADNI cohort","volume":"76","author":"Kim","year":"2011","journal-title":"Neurology"},{"key":"10.14283\/jpad.2024.40_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.clinpsy.032408.153550","article-title":"Advances in analysis of longitudinal data","volume":"6","author":"Gibbons","year":"2010","journal-title":"Annu Rev Clin Psychol"},{"issue":"2","key":"10.14283\/jpad.2024.40_bib18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jamainternmed.2021.7009","article-title":"Association of Systolic Blood Pressure With Dementia Risk and the Role of Age, U-Shaped Associations, and Mortality","volume":"182","author":"van Dalen","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.14283\/jpad.2024.40_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s004150050064","article-title":"Why are stroke patients prone to develop dementia?","volume":"244","author":"Pasquier","year":"1997","journal-title":"J Neurol"},{"issue":"6","key":"10.14283\/jpad.2024.40_bib20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0197-4580(86)90086-2","article-title":"An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease","volume":"7","author":"Hardy","year":"1986","journal-title":"Neurobiol Aging"},{"issue":"15","key":"10.14283\/jpad.2024.40_bib21","doi-asserted-by":"crossref","first-page":"10873","DOI":"10.1074\/jbc.M608856200","article-title":"Hypoxia-inducible factor lalpha (HIF-lalpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation","volume":"282","author":"Zhang","year":"2007","journal-title":"J Biol Chem"},{"issue":"6","key":"10.14283\/jpad.2024.40_bib22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jjcc.2012.08.004","article-title":"Telmisartan protects against cognitive decline via up-regulation of brain-derived neurotrophic factor\/tropomyosin-related kinase B in hippocampus of hypertensive rats","volume":"60","author":"Kishi","year":"2012","journal-title":"J Cardiol"},{"issue":"1","key":"10.14283\/jpad.2024.40_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/01.HYP.24.1.77","article-title":"Potassium inhibits free radical formation","volume":"24","author":"McCabe","year":"1994","journal-title":"Hypertension"},{"issue":"5","key":"10.14283\/jpad.2024.40_bib24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/10641969609081773","article-title":"High potassium diets reduce vascular and plasma lipid peroxides in stroke-prone spontaneously hypertensive rats","volume":"18","author":"Ishimitsu","year":"1996","journal-title":"Clin Exp Hypertens"},{"issue":"5","key":"10.14283\/jpad.2024.40_bib25","first-page":"477","article-title":"Vascular protective effects of potassium","volume":"19","author":"Young","year":"1999","journal-title":"Semin Nephrol"},{"issue":"3","key":"10.14283\/jpad.2024.40_bib26","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3181\/00379727-140-36560","article-title":"The mechanism of the vasodilator action of potassium","volume":"140","author":"Chen","year":"1972","journal-title":"Proc Soc Exp Biol Med"},{"issue":"10","key":"10.14283\/jpad.2024.40_bib27","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1212\/WNL.0b013e3182a351d4","article-title":"Antihypertensive medication use and risk of cognitive impairment: the Honolulu-Asia Aging Study","volume":"81","author":"Gelber","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"10.14283\/jpad.2024.40_bib28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10571-011-9649-6","article-title":"Lercanidipine rescues hippocampus pyramidal neurons from mild ischemia-induced delayed neuronal death in SHRSP","volume":"31","author":"Sakurai-Yamashita","year":"2011","journal-title":"Cell Mol Neurobiol"},{"issue":"3","key":"10.14283\/jpad.2024.40_bib29","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1177\/147323001204000322","article-title":"Nimodipine improves regional cerebral blood flow and suppresses inflammatory factors in the hippocampus of rats with vascular dementia","volume":"40","author":"Zhang","year":"2012","journal-title":"J Int Med Res"},{"issue":"6","key":"10.14283\/jpad.2024.40_bib30","doi-asserted-by":"crossref","first-page":"e65232","DOI":"10.1371\/journal.pone.0065232","article-title":"Unintended effects of cardiovascular drugs on the pathogenesis of Alzheimer's disease","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.14283\/jpad.2024.40_bib31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbr.2012.09.045","article-title":"L-type calcium channel blockade alleviates molecular and reversal spatial learning and memory alterations induced by entorhinal amyloid pathology in rats","volume":"237","author":"Gholamipour-Badie","year":"2013","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.14283\/jpad.2024.40_bib32","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.neurobiolaging.2014.12.027","article-title":"L-type calcium channel blockers and substance P induce angiogenesis of cortical vessels associated with beta-amyloid plaques in an Alzheimer mouse model","volume":"36","author":"Daschil","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.14283\/jpad.2024.40_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pbb.2015.01.015","article-title":"Investigation of the role of non-selective calcium channel blocker (flunarizine) on cerebral ischemic-reperfusion associated cognitive dysfunction in aged mice","volume":"131","author":"Gulati","year":"2015","journal-title":"Pharmacol Biochem Behav"},{"issue":"10","key":"10.14283\/jpad.2024.40_bib34","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/jnr.23406","article-title":"Synergistic neuroprotective effects of combined treatment with olmesartan plus azelnidipine in stroke-prone spontaneously hypertensive rats","volume":"92","author":"Omote","year":"2014","journal-title":"J Neurosd Res"},{"issue":"2","key":"10.14283\/jpad.2024.40_bib35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1447-0594.2011.00746.x","article-title":"Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer's disease","volume":"12","author":"Kume","year":"2012","journal-title":"Geriatr Gerontol Int"},{"key":"10.14283\/jpad.2024.40_bib36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pbb.2014.03.009","article-title":"Non-hypotensive dose of telmisartan and nimodipine produced synergistic neuroprotective effect in cerebral ischemic model by attenuating brain cytokine levels","volume":"122","author":"Justin","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"issue":"9","key":"10.14283\/jpad.2024.40_bib37","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.05.033","article-title":"Strong reduction of low-density lipoprotein receptor\/apolipoprotein E expressions by telmisartan in cerebral cortex and hippocampus of stroke resistant spontaneously hypertensive rats","volume":"23","author":"Zhai","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"10.14283\/jpad.2024.40_bib38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/STROKEAHA.107.495457","article-title":"Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension","volume":"39","author":"Dai","year":"2008","journal-title":"Stroke"},{"issue":"6","key":"10.14283\/jpad.2024.40_bib39","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1161\/STROKEAHA.107.487165","article-title":"Hypertension and cerebral blood flow: implications for the development of vascular cognitive impairment in the elderly","volume":"38","author":"Cohen","year":"2007","journal-title":"Stroke"},{"issue":"7","key":"10.14283\/jpad.2024.40_bib40","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/HJH.0b013e32833951ef","article-title":"Blood pressure, cerebral blood flow, and brain volumes. The SMART-MR study","volume":"28","author":"Muller","year":"2010","journal-title":"J Hypertens"},{"issue":"2","key":"10.14283\/jpad.2024.40_bib41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0197-4580(00)00111-1","article-title":"Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis","volume":"21","author":"de la Torre","year":"2000","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.14283\/jpad.2024.40_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/rej.2009.0878","article-title":"Association between ambulatory 24-hour blood pressure levels and cognitive performance: a cross-sectional elderly population-based study","volume":"13","author":"Beauchet","year":"2010","journal-title":"Rejuvenation Res"},{"issue":"1","key":"10.14283\/jpad.2024.40_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JAD-2009-0925","article-title":"Identification of antihypertensive drugs which inhibit amyloid-beta protein oligomerization","volume":"16","author":"Zhao","year":"2009","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10.14283\/jpad.2024.40_bib44","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archneur.63.5.noc60013","article-title":"Antihypertensive medication use and incident Alzheimer disease: the Cache County Study","volume":"63","author":"Khachaturian","year":"2006","journal-title":"Arch Neurol"},{"issue":"10","key":"10.14283\/jpad.2024.40_bib45","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1017\/S1461145713000631","article-title":"Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice","volume":"16","author":"Dobarro","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"issue":"9137","key":"10.14283\/jpad.2024.40_bib46","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","article-title":"Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial","volume":"352","author":"Forette","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.14283\/jpad.2024.40_bib47","article-title":"Nimodipine for primary degenerative, mixed and vascular dementia","author":"Lopez","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.14283\/jpad.2024.40_bib48","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/HYPERTENSIONAHA.119.12892","article-title":"Effects of Nilvadipine on Cerebral Blood Flow in Patients With Alzheimer Disease","volume":"74","author":"de Jong","year":"2019","journal-title":"Hypertension"},{"issue":"4","key":"10.14283\/jpad.2024.40_bib49","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/HJH.0000000000000086","article-title":"Angiotension receptor blockers reduce the risk of dementia","volume":"32","author":"Chiu","year":"2014","journal-title":"J Hypertens"},{"issue":"2","key":"10.14283\/jpad.2024.40_bib50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1253\/circj.CJ-12-0658","article-title":"Angiotensin-receptor blockers and risk of Alzheimer's disease in hypertension population\u2014a nationwide cohort study","volume":"77","author":"Hsu","year":"2013","journal-title":"Cire J"},{"issue":"4","key":"10.14283\/jpad.2024.40_bib51","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3233\/JAD-2012-121090","article-title":"Associations of angiotensin targeting antihypertensive drugs with mortality and hospitalization in primary care patients with dementia","volume":"33","author":"Kehoe","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.14283\/jpad.2024.40_bib52","doi-asserted-by":"crossref","first-page":"b5465","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis","volume":"340","author":"Li","year":"2010","journal-title":"Bmj"},{"issue":"45","key":"10.14283\/jpad.2024.40_bib53","doi-asserted-by":"crossref","first-page":"37644","DOI":"10.1074\/jbc.M508460200","article-title":"Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor","volume":"280","author":"Hemming","year":"2005","journal-title":"The Journal of biological chemistry"},{"issue":"5","key":"10.14283\/jpad.2024.40_bib54","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s10930-013-9492-3","article-title":"Molecular dynamics simulation and molecular docking studies of Angiotensin converting enzyme with inhibitor lisinopril and amyloid Beta Peptide","volume":"32","author":"Jalkute","year":"2013","journal-title":"The protein journal"},{"issue":"6","key":"10.14283\/jpad.2024.40_bib55","first-page":"e67","article-title":"Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association","volume":"68","author":"Iadecola","year":"2016","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"issue":"9","key":"10.14283\/jpad.2024.40_bib56","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association\/american stroke association","volume":"42","author":"Gorelick","year":"2011","journal-title":"Stroke"},{"issue":"2","key":"10.14283\/jpad.2024.40_bib57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jagp.2012.08.017","article-title":"Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele","volume":"22","author":"Qiu","year":"2014","journal-title":"Am J Geriatr Psychiatry"},{"issue":"12","key":"10.14283\/jpad.2024.40_bib58","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/0028-3908(95)00146-8","article-title":"Effect of chronic treatment with trandolapril or enalapril on brain ACE activity in spontaneously hypertensive rats","volume":"34","author":"Jouquey","year":"1995","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.14283\/jpad.2024.40_bib59","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.amjhyper.2004.09.004","article-title":"Inhibition of brain angiotensin-converting enzyme by peripheral administration of trandolapril versus lisinopril in Wistar rats","volume":"18","author":"Tan","year":"2005","journal-title":"Am J Hypertens"},{"issue":"13","key":"10.14283\/jpad.2024.40_bib60","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archinternmed.2009.175","article-title":"Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study","volume":"169","author":"Sink","year":"2009","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.14283\/jpad.2024.40_bib61","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3233\/JAD-130716","article-title":"Angiotensin converting enzyme inhibitors and the reduced risk of Alzheimer's disease in the absence of apolipoprotein E4 allele","volume":"37","author":"Qiu","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10.14283\/jpad.2024.40_bib62","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jalz.2011.05.2414","article-title":"Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus","volume":"8","author":"Johnson","year":"2012","journal-title":"Alzheimers Dement"},{"issue":"9","key":"10.14283\/jpad.2024.40_bib63","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/jgs.12415","article-title":"Angiotensin-converting enzyme inhibitors and Alzheimer's disease progression in older adults: results from the R\u00e9seau sur la Maladie d'Alzheimer Fran\u00e7ais cohort","volume":"61","author":"Soto","year":"2013","journal-title":"J Am Geriatr Soc"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T23:35:49Z","timestamp":1736465749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724000591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2274580724000591"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2024.40","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Hypertensive Drugs Moderate the Relationship of Blood Pressure with Alzheimer's Pathologies and Neurodegenerative Markers in Non-Demented Hypertensive Older Adults","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2024.40","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}